VANDA PHARMACEUTICALS INC
VANDA PHARMACEUTICALS INC
Action · US9216591084 · VNDA · A0JJT3 (XNMS)
Aperçu Indicateurs financiers
4,62 USD
3,82 % 0,17 USD
NASDAQ/NMS (GLOBAL MARKET) (XNAS) · Cours et graphiques actuels sur MoneyPeak
06.06.2025 22:04

Cours actuels de VANDA PHARMACEUTICALS INC

BourseTickerDeviseDernier échangeCoursVariation journalière
XNAS: NASDAQ
NASDAQ
VNDA
USD
06.06.2025 22:04
4,62 USD
4,39 USD
+5,24 %

Performance

Jour Semaine Mois 3 mois 6 mois 1 an 5 ans
0,00 % 7,94 % 5,72 % -5,91 % -4,55 % -26,32 % -59,69 %

Profil de l'entreprise pour VANDA PHARMACEUTICALS INC Action

Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under development include HETLIOZ (tasimelteon) for the treatment of jet lag disorder, smith-magenis syndrome, pediatric Non-24, autism spectrum, and delayed sleep phase disorder; Fanapt (iloperidone) for the treatment of bipolar disorder and a long acting injectable formulation program for the treatment of schizophrenia; and Tradipitant (VLY-686), a small molecule neurokinin-1 receptor (NK-1R) antagonist, for the treatment of atopic dermatitis, gastroparesis, and motion sickness. The company's products under development also comprise VTR-297, a small molecule histone deacetylase inhibitor for the treatment of hematologic malignancies and with potential use as a treatment for various oncology indications; VQW-765, a small molecule nicotinic acetylcholine receptor partial agonist for the treatment of psychiatric disorders; a portfolio of cystic fibrosis transmembrane conductance regulator activators and inhibitors for the treatment of dry eye and ocular inflammation, as well as BPO-27 for the treatment of secretory diarrhea disorders, including cholera; and VHX-896, the active metabolite of iloperidone. It markets its products in the United States, Europe, and Israel. Vanda Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in Washington, the District of Columbia.

Fonds investis

Les fonds suivants ont investi dans : VANDA PHARMACEUTICALS INC investi :

Fonds
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. en millions
29,72
Part (%)
0,07 %

Données de l'entreprise

Nom VANDA PHARMACEUTICALS INC
Société Vanda Pharmaceuticals Inc.
Symbole VNDA
Site web https://www.vandapharma.com
Marché d'origine XNMS NASDAQ/NMS (GLOBAL MARKET)
WKN A0JJT3
ISIN US9216591084
Type de titre Action
Secteur Healthcare
Industrie Biotechnology
PDG Dr. Mihael H. Polymeropoulos M.D.
Capitalisation boursière 255 Mio
Pays États-Unis d'Amérique
Devise USD
Employés 0,4 T
Adresse 2200 Pennsylvania Avenue NW, 20037 Washington
Date d'introduction en bourse 2006-04-12

Symboles boursiers

Nom Symbole
Frankfurt VM4.F
NASDAQ VNDA

Autres actions

Les investisseurs qui détiennent VANDA PHARMACEUTICALS INC ont également les actions suivantes dans leur portefeuille :
AMGEN INC
AMGEN INC Action
ANSYS INC
ANSYS INC Action
AUTODESK INC
AUTODESK INC Action
BNPP EURO MID CAP CCL
BNPP EURO MID CAP CCL Fonds
CISCO SYSTEMS INC
CISCO SYSTEMS INC Action
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Action
IMMUTEP LTD
IMMUTEP LTD Action
INCYTE CORP
INCYTE CORP Action
INTEL CORP
INTEL CORP Action
MALVERN INTERNATIONAL PLC - ORD 0.1P
MALVERN INTERNATIONAL PLC - ORD 0.1P Action
MICROSOFT CORP
MICROSOFT CORP Action
MONDELEZ INTERNATIONAL INC - CLASS A
MONDELEZ INTERNATIONAL INC - CLASS A Action
WACKER NEUSON SE
WACKER NEUSON SE Action
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Action
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025